Here, we demonstrated that MitoX-based chemotherapy, which has been widely used to treat various types of cancer (but not melanoma), induced autophagy-mediated PAI-1 secretion, thereby contributing to the resistance of melanoma to this chemotherapeutic agent. Here, SERPINE1 is linked to cancer.